Blood Res 2017; 52(1):
Published online March 27, 2017
https://doi.org/10.5045/br.2017.52.1.65
© The Korean Society of Hematology
1Department of Pathology, University College of Medical Sciences & GTB Hospital, Delhi, India.
2Department of Medicine, University College of Medical Sciences & GTB Hospital, Delhi, India.
Correspondence to : Vandana Puri. Department of Pathology, University College of Medical Sciences & GTB Hospital, Dilshad Garden, Delhi 110095, India. drvandanapuri@gmail.com
Blood Res 2017; 52(1): 65-67
Published online March 27, 2017 https://doi.org/10.5045/br.2017.52.1.65
Copyright © The Korean Society of Hematology.
Vandana Puri1*, Pooja Sharma1, Sundaram Gopalakrishnan2, Meera Sikka1, and Rajnish Avasthi2
1Department of Pathology, University College of Medical Sciences & GTB Hospital, Delhi, India.
2Department of Medicine, University College of Medical Sciences & GTB Hospital, Delhi, India.
Correspondence to: Vandana Puri. Department of Pathology, University College of Medical Sciences & GTB Hospital, Dilshad Garden, Delhi 110095, India. drvandanapuri@gmail.com
The blasts population showed expression of CD19, TdT, and CD79a, consistent with B-cell acute lymphoblastic leukemia.
Table 1 . Results of clinical chemistry tests..
The blasts population showed expression of CD19, TdT, and CD79a, consistent with B-cell acute lymphoblastic leukemia.